Key Takeaways on Sustainability from Biologics 2024
Biologics 2024, held in London from March 13th to 15th, provided crucial insights into the pharmaceutical industry’s evolving landscape. Our Business Development Representative, Alejandro Picardi, attended the event to share Stämm’s perspective and gain key data from industry experts. Organized by Oxford Global, this event serves as a vital platform for networking among top-tier pharmaceutical companies and facilitating in-depth scientific discussions.
Focusing on drug discovery and biological research, Biologics 2024 emphasized the importance of upstream processes in the value chain—essential for driving the industry forward.
A standout session, Sustainability in Biologics Manufacturing, sparked engaging conversations about the critical need to integrate sustainability into manufacturing practices. Attendees highlighted the necessity of not only implementing practical changes but also advocating for regulatory frameworks that support these advancements.
Overall, Biologics 2024 fostered significant discussions that will influence future strategies in drug development and sustainability, reinforcing its role as a key event in the pharmaceutical calendar.
Advanced Therapies Congress: Europe’s Premier Cell and Gene Therapy Event
The Advanced Therapies Congress, also held in London, emerged as Europe’s largest event dedicated to cell and gene therapy. Over two days, it brought together a diverse group of speakers from all areas of therapy development, highlighting the latest innovations and trends.
The event featured a broad range of exhibitors, from research and biomanufacturing to logistics, laboratory infrastructure, construction, and consulting services. This rich diversity created opportunities for valuable insights and connections, driving collaboration and innovation across the industry.
Key topics throughout the event included Quality, Speed, Automation, Transparency, Regulatory Compliance, and Predictability. These concepts are essential for navigating the complexities of the cell and gene therapy landscape, ensuring that companies remain competitive and responsive to market needs.
Conclusion
As the industry continues to evolve, these events highlight the importance of collaboration and strategic thinking in shaping the future of drug development and therapeutic advancements.
Stay tuned for more insights and developments as we continue to engage with the dynamic world of biologics and biomanufacturing.